Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5580355 | 0.85 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL1140512 | 0.85 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1603239 | 0.83 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL1603587 | 0.79 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL118947 | 0.79 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL43574 | 0.79 | EGLN1 (0.43) | ALDH1A1 | |
| SCHEMBL233404 | 0.77 | ALDH1A1 (0.68) | ALDH1A1 | |
| SCHEMBL3555482 | 0.77 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL2454640 | 0.77 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL1895096 | 0.77 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4749282-A2 | HOMOGENOUS IMMUNOASSAY WITH COMPENSATION FOR BACKGROUND SIGNAL | IDEXX Laboratories, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2026-02-12 | — | — | US | claimed |
| US-20260035410-A1 | THERAPEUTIC PEPTIDES AND METHODS OF PEPTIDE DESIGN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2026-02-05 | — | — | US | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| EP-4313009-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2023220678-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY (US) | 2023-11-16 | — | — | WO | claimed |
| US-20230270882-A1 | PEPTIDE-NANOPARTICLE CONJUGATES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2023-08-31 | — | — | US | claimed |
| EP-4204013-A1 | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2023-07-05 | — | — | EP | claimed |
| US-11685960-B2 | Rapid nucleic acid detection without sample preparation | CROSSLIFE TECHNOLOGIES INC. (US) | 2023-06-27 | — | — | US | claimed |
| CN-115997016-A | Composition comprising nucleic acid nanoparticles having modular functional groups | 西克斯福德生物科学有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-106659790-A | Anti-CDH6 antibody drug conjugates | 诺华股份有限公司 | 2017-05-10 | — | — | CN | claimed |
| US-20160193355-A1 | Novel linker, preparation method, and application thereof | QIN GANG (CN) | 2016-07-07 | — | — | US | claimed |
| WO-2016005474-A1 | SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN | AFFYCON APS (DK) | 2016-01-14 | — | — | WO | claimed |
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| EP-2675480-A1 | METHODS OF PREPARATION OF CONJUGATES | ImmunoGen, Inc. (US) | 2013-12-25 | — | — | EP | claimed |
| US-8420802-B2 | Polymer support | UNIVERSITY OF CAPE TOWN (ZA) | 2013-04-16 | — | — | US | claimed |
| WO-2012112687-A1 | METHODS OF PREPARATION OF CONJUGATES | IMMUNOGEN, INC. (US) | 2012-08-23 | — | — | WO | claimed |
| EP-2478049-A1 | A POLYMER SUPPORT | University of Cape Town (ZA) | 2012-07-25 | — | — | EP | claimed |
| US-20120178916-A1 | Polymer Support | UNIVERSITY OF CAPE TOWN (ZA) | 2012-07-12 | — | — | US | claimed |
| WO-2011083360-A1 | A POLYMER SUPPORT | UNIVERSITY OF CAPE TOWN (ZA) | 2011-07-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | RNMT, SMCHD1, PKLR | ALDH1A1 2870/4885 |
| US-20160193355-A1 | Novel linker, preparation method, and application thereof | ENGASE, SORT1, DNPEP | ALDH1A1 837/4885 |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | ALDH1A1 2270/4885 |
| US-20260035410-A1 | THERAPEUTIC PEPTIDES AND METHODS OF PEPTIDE DESIGN | MICA, IGSF11, TNFSF10 | ALDH1A1 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.